null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Anti-KCNQ4 Antibody [N43/6 (Formerly sold as S43-6)]

SKU STMA00086
Antibody Type Monoclonal
Applications WB
Applications IHC
Applications ICC/IF
Applications AM
Reactivity Human
Reactivity Mouse
Reactivity Rat
Host Species Mouse
Isotype IgG1
€647
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

KCNQ4 Antibody [N43/6 (Formerly sold as S43-6)]

KCNQ4 Antibody [N43/6 (Formerly sold as S43-6)] is a mouse monoclonal antibody directed against KCNQ4, offered by Assay Genie for research applications. Reported applications include WB, IHC, ICC/IF and AM. Reported reactivity: Human, Mouse and Rat. Supplied as IgG1, purified by Protein G.

KCNQ4 encodes a voltage-gated potassium channel subunit that plays a vital role in regulating neuronal excitability, particularly in sensory systems. Predominantly expressed in the outer hair cells of the cochlea, KCNQ4 contributes to potassium ion efflux, maintaining the resting membrane potential and enabling precise auditory signal transduction. This channel is modulated by key signaling pathways: it is inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a potassium channel opener with anticonvulsant properties. These regulatory mechanisms highlight KCNQ4’s importance in maintaining excitatory-inhibitory balance in neurons. Mutations or dysfunction in KCNQ4 are strongly associated with progressive sensorineural hearing loss (DFNA2), but emerging evidence suggests broader implications in neurodegenerative disease. Disrupted potassium channel activity can lead to chronic neuronal hyperexcitability, oxidative stress, and eventual neurodegeneration—mechanisms shared across conditions such as Alzheimer’s disease, epilepsy, and age-related hearing loss. Given its pharmacological responsiveness and role in sensory neuron stability, KCNQ4 is gaining attention as a potential therapeutic target. Enhancing its function may offer neuroprotective benefits by restoring ionic homeostasis and preventing excitotoxic damage in vulnerable neural circuits. As research into ion channelopathies expands, KCNQ4 stands out as a key player in both auditory neuroscience and the broader landscape of neurodegenerative disease research. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose